Aaron Cravens PhD

Aaron co-founded Revel in 2019 inspired by the potential impact anti-AGE therapeutics could have on patients. He is thrilled to lead the development of the team and technology that will take anti-AGE therapeutics into the clinic. Before Revel, Aaron worked at Google X and consulted for Bay Area biotech companies, where he developed operational and leadership experience. He previously founded a startup in the skincare space and trained in Stanford’s IGNITE Business School Program. Aaron has over eight years of experience in Revel’s platform technologies of enzyme discovery and engineering. Aaron earned his BS in Mathematics from the University of Rochester and his Ph.D. in Bioengineering from Stanford University, advised by Dr. Christina Smolke.